Verocytotoxine-producing Escherichia coli infection in hemolytic uremic syndrome in part of Western Europe. by Kar, N.C.A.J. van de et al.






The following full text is a publisher's version.
 
 





Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
Eur J Pediatr (1996) 155:592-595 
© Springer-Verlag 1996
Nicole C. A. J. van de Kar 
Hannie G. R. Roelofs 
Harry L. M uytjens 
Jules J. M. Tolboom  
Bernhard Roth 
Willem Proesmans 
Willy C. C, Reitsma-Bierens 
Eric D. Wolff 
Mohamed A. Karmali 
Henrik Chart 
Leo A. H. Monnens
Verocytotoxin-producing Escherichia coli 
infection in hemolytic uremic syndrome 
in part of Western Europe
Received: 2 August 1994 
Accepted: 5 December 1995
N. C. A. J. van de Kar (E3)
J. J. M. Tolboom • L. A. H. Monnens 
Department of Paediatrics,
University Hospital,
Geert Grooteplein Zuid 20,
P.O. Box 9101,
6500 HB Nijmegen, The Netherlands 
Tel.: 31.24.3616872 
Fax: 31.24.3616428
H. G. R. Roelofs • H. L. Muytjens 





University of Cologne, Cologne, Germany
W. Proesmans 
Department of Paediatrics,










Department of Medical Microbiology, 
Hospital for Sick Children,
Toronto, Canada
H. Chart
Central Public Health Laboratory, 
Divisions of Enteric Pathogens,
London, United Kingdom
Abstract From September 1989 un­
til September 1993, stool specimens 
and sera from 113 children with diar­
rhoea-associated haemolytic uraemic 
syndrome (HUS) from the Nether­
lands, two university hospitals in 
Belgium and one university hospital 
in Germany were examined for the 
presence of verocytotoxin-producing 
Escherichia coli (VTEC) infection. 
Evidence for VTEC infection was 
observed in 88 (78%) patients with 
HUS compared to 2 (3%) of the 65 
children with acute gastro-enteritis 
Serotype 0157  was the causative 
agent in 76 (86%) of these 88 pa­
tients with VTEC-associated HUS 
and verocytotoxin-2 (VT-2) was the 
m ost frequent toxin produced. Sero­
logical testing for antibodies to 0 1 5 7  
O-antigen yielded the highest num ­
ber of positive results compared to 
the other test methods. Antibodies to 
0157  were found in sera of 71 (65%) 
of 110 patients with HUS and one 
control serum. Stool and sera exami­
nation for VTEC in 95 family con­
tacts of 28 patients with HUS demon­
strated an evidence for VTEC infec­
tion 33 (35%). In contrast, in patients 
with HUS serological antibodies to 
0157  O-antigen were found in only 
3 (4%) of 85 family contacts.
Conclusion In this part of Western 
Europe, VT2-producing Escherichia 
coli, mainly those belonging to 
serogroup 0157, are the major cause 
of HUS in childhood.
Key words Haemolytic uraemic 
syndrome • Verocytotoxin-producing 
Escherichia coli • Epidemiology
Abbreviations HUS  haemolytic 
uraemic syndrome •





Haemolytic uraemic syndrome (HUS), preceded by an acute, 
often bloody gastro-enteritis, is mostly seen in children 
and is a major cause of acute renal failure in childhood 
[9]. Since the first report by Karmali and coworkers [8], 
verocytotoxin-producing Escherichia coii (VTEC) infec­
tions are recognized as an important cause of diarrhoea- 
associated HUS in the United States, Canada, and United 
Kingdom [3], VTEC strains may belong to different sero- 
groups, but the most commonly isolated VTEC is the 
serotype 0157 :H7. A family of at least three verocyto- 
toxins (VT) has been identified: VT1 or Shiga-like toxin 
I, VT2 or Shiga-like toxin II and VT-2 variants. Not all 
those infected with VTEC will develop HUS. Infection 
with VTEC can be asymptomatic, can lead to a mild diar­
rhoea, bloody diarrhoea, haemorrhagic colitis or HUS [3], 
In this study, we report the results of a 4 -year prospective 
study in which we examined the presence of VTEC infec­
tion in patients with diarrhoea-associated HUS in the 
Netherlands, two adjacent university hospitals in Belgium 
and one in Germany at a distance of approximately 150 
km from the University of Nijmegen, The Netherlands.
Patients and methods
Patients
Between September 1989 and September 1993, stool and sera spec­
imens from 113 patients with diarrhoea-associated HUS (58 female, 
55 male; mean age ± SD: 46 ± 35 months; range 9-162 months) 
were received by the Department of Medical Microbiology of the 
University Hospital Nijmegen for examination of the presence of 
VTEC infection. Specimens of patients with HUS were obtained 
from 77 Dutch patients admitted to paediatric nephrology depart­
ments of the academic hospitals in the Netherlands, 21 patients ad­
mitted to the paediatric nephrology department of the Children’s 
Hospital, Cologne in Germany and 15 patients admitted to the Uni­
versity Hospitals of Leuven and Antwerp in Belgium. HUS was 
determined by a sudden onset of illness with a prodromal phase of 
acute gastro-enteritis and by laboratory evidence of microangio­
pathic haemolytic anaemia, thrombocytopenia and disturbed renal 
function [6]. All patients with HUS included in this study had a 
prodromal phase with acute gastro-enteritis; in 83 (73%) of the 
HUS patients the gastro-enteritis was reported to be bloody. Stool 
and serum specimens were also obtained from 95 family contacts 
(27 fathers, 28 mothers, 35 siblings and two other family contacts) 
of all the 28 patients with HUS referred to the paediatric depart­
ment of the University Hospital, Nijmegen, The family members 
included all family contacts who lived with the HUS index case in 
the same house. The control group consisted of 65 children (28 fe­
males, 37 males, mean age ± SD; 31+25 months) with acute gas- 
tro-enterities and without any evidence of HUS, who were admit­
ted to the paediatric department of the University Hospital Ni­
jmegen and to three hospitals in the Netherlands between Septem­
ber 1990 and September 1993. Of the controls, 1 1  patients (18%) 
had bloody diarrhoea. On admission, stools were collected from 
patients and controls as soon as possible. Blood samples were 
taken on admission, and when possible, after 2 to 3 weeks (conva­
lescent phase). After centrifugation sera samples were frozen at 
- 20°C and transported on dry ice to the medical microbiology de­




All stool samples examined for VTEC were plated on sorbitol 
MacConkey (Oxoid Sorbitol MacConkey agar containing 1% sor­
bitol) and blood agar. After 24 h incubation, non-sorbitol ferment­
ing, colourless colonies were tested for agglutination with anti-
0157 O-antigen serum (Difco, Detroit, Michigan, USA) and tested 
for VT activity in the Verocell assay. VTEC 0157 strains were 
serotyped by Dr. W. Jansen, RIVM, Bilthoven, the Netherlands. 
Furthermore, faecal samples were tested by a procedure for VT de­
tection in polymyxin B extracts of colony sweeps and for free fae­
cal VT as described by Karmali et al. [8], The stools of all patients 
with HUS and patients with acute gastro-enteritis were also tested 
for the most common enteric pathogens.
Serum samples
Paired serum samples, collected on admission and after 14 days were 
used to detect neutralizing ability to VT1 and VT2 or VT variants 
with the Verocell assay [8]. Paired samples were always tested in 
the same Verocell microtitre plate. A fourfold or more rising titre 
to VTI, VT2 and/or VT variants in the sera was regarded as posi­
tive for recent VTEC infection. Serum antibodies to the lipopoly- 
saccharide of E. coli 0157 were analysed by ELISA and immuno- 
blotting, as described previously [5]. A case was defined positive 
for VTEC infection when one or more of the above described de­
tection methods were positive.
Statistical analysis
The significance of differences between the groups was determined 
by using the Fisher’s exact test (two tailed).
Results
The results are shown in Table 1, Evidence for VTEC in­
fection was found in 88 (78%) out of 11.3 patients with 
HUS. Only two patients (3%) from the control group o f  
65 children with acute gastro-enteritis demonstrated a 
VTEC infection. All 19 isolated strains demonstrated cy­
totoxicity in the Verocell assay which could be neutralized 
by polyclonal antibodies to VT2 alone. Infection with 
Shigella dysenteriae I  occurred in one patient with HUS. 
No Campylobacter, Salmonella  or Yersinia species were 
isolated in the stool of the HUS group. Evidence for 
Clostridium difficile infection was found in three patients 
with HUS. One HUS patient had both E. coli 0 1 5 7  :H7 
and Clostridium difficile in the stool. The observed cyto­
toxicity observed in the Verocell assays for both culture 
and fecal filtrate was in all, except two, cases neutraliz- 
able with antibodies to VT2. Antibodies to VT 1 neutral­
ized the cytotoxic effect in the filtrates of two HUS pa­
tients.
E. coli 0 1 5 7  :H -  was isolated in two control cases. 
One strain E. coli 0 1 5 7  :H -  was isolated from the non-
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Table 1 VTEC infection in 
patients with HUS and controls 
with acute gastro-enteritis
ilThe other isolated E. coli 
0 157: H- strain in the control 
group did not produce VT and 
is not included. Ali methods, 
except the assay for VT-neu- 
Lralizmg ability, had P < 0.001 
compared with controls, 
VTJPECS VT detection in 
polymyxin B extracts of 
colony sweaps
Table 2 Evidence for VTEC 
infection in 28 patients with 
HUS and their family contacts
"Evidence for VTEC infection 
in family contacts was most 
prominent in the siblings of the 
patient (49%); Evidence for 
VTEC infection in mothers or 
fathers of the patient was pre­
sent in 18% and 26% of the 
parents respectively. *P < 0.0 1 , 
** P < 0.001 compared with 
family-m embers.
VTJPECS VT detection in 
polymyxin B extracts of 
colony sweaps
Methods No. of patients with HUS 
positive for VTEC
(n = 113)
No. of controls 
positive for VTEC 
(n -  65)
Faeces
Isolation of VTEC 0157 19/90 (21%) 1/57 (2%)
0157 :H7 18/19 (95%) 0/57 (0%)
0157 :H - 1/19 (5%) 1/57 (2%)u
VT/PECS 24/90 (27%) 1/57 (2%)
Free faecal VT 49/90 (54%) 1/56 (2%)
Serology
VT-neutralizing ability 4/ 76 (5%) 0/19 (0%)
Antibodies to 0157-antigen 71/110 (65%) 1/53 (2%)
Total VTEC infection 88/113 (78%) 2/65 (3%)
Methods No. of patients with HUS No. of family
positive for VTEC members positive
for VTEC'
(n = 28) (n = 95)
Faeces
Isolation of VTEC strain 5/26 (19%) 16/81 (20%)
VT/PECS 10/26 (26%) 23/81 (28%)
Free faecal VT 18/26 (69%)* 25/75 (33%)
Serology
VT-neutralizing ability 1/25 (4%) 2/54 (4%)
Antibodies to 0157-antigen 21/28 (75%)** 3/85 (4%)
Total VTEC infection 26/28 (93%) 33/95 (35%)
bloody stool of a patient with coeliac disease; however, 
this strain did not dem onstrate any cytotoxicity in the Ve- 
rocell assay. The other E . coli 0 1 5 7 :  H -  strain (V T1-V T2 
producer) was found in the stool of a patient with acute, 
bloody gastro-enteritis. O ther enteric pathogens isolated 
from the stool of control cases were Salmonella spp  (11 
x), rotavirus (9 x), adenovirus (3 x), enterovirus (3 x), 
Campylobacter je ju n i  (3 X), Giardia lamblia (2 x) and 
Coxsackie virus, Yersinia and Clostridium difficile (1 x).
The Verocell assay for neutralizing ablity to VT was 
positive in paired sera samples from  4 (5%) of the 76 pa­
tients with HUS (Table 1). All detected neutralizing abil­
ity to VT were against VT1 not to VT2 or VT variants. 
Antibodies to 0 1 5 7  O-antigen were present in 71 (65%) 
o f the 110 tested HUS patients and in 1 (2%) of the 53 
control cases. A lthough no further investigation was done 
to identify the V TEC  strains with serotypes other than 
serogroup 0 1 5 7 , com bining the results of stool and sera 
examinations, V TEC  infection due to serotype 0157  was 
present in 76 (86%) of the 88 cases.
Stool and sera exam ination were performed in 95 fam ­
ily contacts of 28 patients w ith HUS. Sixteen (17%) fam ­
ily members had diarrhoea at time o f  admission or 1 week 
before admission of the HUS case to the hospital; none of 
the ten adults had bloody diarrhoea, in four o f  the six sib­
lings the diarrhoea was bloody. The results are shown in
Table 2. In 17 (61%) families one or more members were 
found to have a V TEC  infection at the time the patient 
was admitted to the hospital. Thirty-three (35%) family 
members had evidence of VTEC infection; 50% of these 
family members had diarrhoea. Evidence for VTEC infec­
tion was m ost prominent in the siblings of the patient 
(49%). All the 16 isolated VTEC 0157  strains of family 
members produced VT2. Only 3 of the 85 family m em ­
bers, children of 1 ,4 ,  and 6 years of age, had serum anti- 
bodies to the 0 1 5 7  O-antigen. All three children had diar­
rhoea. Bloody diarrhoea was a more prominent feature of 
VTEC infection in patients with HUS than in the family 
members and correlated significantly with the presence of 
antibodies to 0 1 5 7  antigen (P < 0.05).
Discussion
Combined microbiological and serological procedures pro­
vided evidence for VTEC infection in 78% of the patients 
with HUS com pared with 3%  in the control group of chil­
dren with acute gastro-enteritis. Serotype 0157  was the 
predominant cause o f  VTEC-associated HUS in our pa­
tients. All isolated V TEC 0 1 5 7  strains were VT2 produc­
ers only. These results are comparable with other Euro­
pean epidemological studies [1, 4, 12]. VT2-producing
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strains have been associated with a higher frequency of 
systemic complications in human diseases [2 , 1 2 ]; how ­
ever, a recently published Canadian study reported that 22 
out of the 26 VTEC 0 1 5 7 : H7 isolated from HUS patients 
were both VT1 and VT2 producers [10].
fection in one family was due to  the same strain of E. coli 
0157  [7]. These family studies might indicate that other, 
yet unknown, host factors in the  intestine are involved in 
making it more easier for V T E C  lipopolysaccharides to 
cross the mucosal surface. A  difference in adherence of
In this study serological examination for antibodies to VTEC to the intestinal ep ithelium  of adults and children
might be an explanation for the  occurrence of HUS in 
mostly children as com pared to  adults.
Several outbreaks of VTEC in fection by strains of E, coli 
for several weeks after the onset of diarrhoea [5]. The of serotype 0 1 5 7 : PI7 in the U nited States and Canada have 
lower detection percentage of VTEC from stool, is proba- revealed that the major route o f  acquisition of VTEC seems
0157 was the most successful method compared to the 
stool examination. Serological testing for antibodies to 
0157 O-antigen can provide evidence of VTEC infection
bly due to the fact that the recovery rate for VTEC from 
stool depends on the interval of days between the onset of 
symptoms and the collection of stool. Tarr et al, [11] re­
ported that this rate decreased from 100% to 33% if the 
stool was cultured within 2 days or 1 week after the diar­
rhoea began. In our study, stool was sampled 7 ±  3 (SD) 
days after the onset of diarrho.
Combined faecal and serological tests demonstrated a 
VTEC infection in 33 (35%) of the 95 family members of 
HUS patients. It is remarkable that although VTEC infec­
tion could often be demonstrated in the stool of family 
members, serum antibodies to 0157  O-antigen were sig­
nificantly lower in the family members as compared to the 
patients. The three family members who were positive for 
serum antibodies 0 1 5 7  LPS, were children. VTEC 0157  
isolates presented in this study have recently been charac­
terized by phase typing, polymerase chain reaction for VT 
genes, E . coli attaching and effacing (eae) gene and ran­
dom  amplified polymorphic DNA fingerprinting. No dif­
ferences were found in the strains isolated from different 
persons within one family, demonstrating that VTEC in­
to be the consumption of contam inated  meat, unpasteur- 
ized milk, exposure to contam inated  water, and through 
person-to-person transmission [3]. A lthough there is some 
indication that in our family study VTEC transmission 
through person-to-person contact might be very important, 
this study was not designed to detect the source of VTEC.
We conclude that in part o f  W estern Europe, VT2-pro- 
ducing Escherichia coli, m ainly  those belonging to sero- 
group 0157 , are the major cause  o f  HUS in childhood. 
Further studies to establish the source of these strains are 
currently in progress.
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